Chloroquine remains the treatment of choice for vivax malaria, except in Indonesia's Irian Jaya (Western New Guinea) region and the geographically contiguous Papua New Guinea, where chloroquine resistance is common (up to 20% resistance).
Klorokin ostaje tretman za vivax malariju, izuzev u Indoneziji i Papui Novoj Gvineji, gdje je otpornost mikroorganizma na klorokin česta (i do 20%).